These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21339733)

  • 1. TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression.
    Seux M; Peuget S; Montero MP; Siret C; Rigot V; Clerc P; Gigoux V; Pellegrino E; Pouyet L; N'Guessan P; Garcia S; Dufresne M; Iovanna JL; Carrier A; André F; Dusetti NJ
    Oncogene; 2011 Jul; 30(27):3049-61. PubMed ID: 21339733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.
    Fenouille N; Robert G; Tichet M; Puissant A; Dufies M; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
    Pigment Cell Melanoma Res; 2011 Feb; 24(1):219-32. PubMed ID: 20955243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas.
    Al Saati T; Clerc P; Hanoun N; Peuget S; Lulka H; Gigoux V; Capilla F; Béluchon B; Couvelard A; Selves J; Buscail L; Carrier A; Dusetti N; Dufresne M
    Am J Pathol; 2013 Jun; 182(6):1996-2004. PubMed ID: 23578383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
    Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
    Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinoma.
    Weng W; Yang Q; Huang M; Qiao Y; Xie Y; Yu Y; jing A; Li Z
    Biochem Biophys Res Commun; 2011 Feb; 405(2):278-84. PubMed ID: 21219856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function.
    Cano CE; Gommeaux J; Pietri S; Culcasi M; Garcia S; Seux M; Barelier S; Vasseur S; Spoto RP; Pébusque MJ; Dusetti NJ; Iovanna JL; Carrier A
    Cancer Res; 2009 Jan; 69(1):219-26. PubMed ID: 19118006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells.
    Wei Q; Li YX; Liu M; Li X; Tang H
    IUBMB Life; 2012 Aug; 64(8):697-704. PubMed ID: 22730212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
    Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
    J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of tumor suppressor tumor protein 53-induced nuclear protein 1 (TP53INP1) sensitizes mouse thymocytes and embryonic fibroblasts to redox-driven apoptosis.
    N'guessan P; Pouyet L; Gosset G; Hamlaoui S; Seillier M; Cano CE; Seux M; Stocker P; Culcasi M; Iovanna JL; Dusetti NJ; Pietri S; Carrier A
    Antioxid Redox Signal; 2011 Sep; 15(6):1639-53. PubMed ID: 21235351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A positive feedback loop of p53/miR-19/TP53INP1 modulates pancreatic cancer cell proliferation and apoptosis.
    Wang X; Wang L; Mo Q; Jia A; Dong Y; Wang G
    Oncol Rep; 2016 Jan; 35(1):518-23. PubMed ID: 26531836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
    Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
    Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma.
    Ito Y; Motoo Y; Yoshida H; Iovanna JL; Takamura Y; Miya A; Kuma K; Miyauchi A
    Anticancer Res; 2006; 26(6B):4391-5. PubMed ID: 17201159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
    Puolakkainen PA; Brekken RA; Muneer S; Sage EH
    Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
    Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
    Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of SPARC--matricellular protein in pathophysiology and tissue injury healing. Implications for gastritis and gastric ulcers.
    Phan E; Ahluwalia A; Tarnawski AS
    Med Sci Monit; 2007 Feb; 13(2):RA25-30. PubMed ID: 17261993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.
    Gironella M; Seux M; Xie MJ; Cano C; Tomasini R; Gommeaux J; Garcia S; Nowak J; Yeung ML; Jeang KT; Chaix A; Fazli L; Motoo Y; Wang Q; Rocchi P; Russo A; Gleave M; Dagorn JC; Iovanna JL; Carrier A; Pébusque MJ; Dusetti NJ
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16170-5. PubMed ID: 17911264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells.
    Sosa MS; Girotti MR; Salvatierra E; Prada F; de Olmo JA; Gallango SJ; Albar JP; Podhajcer OL; Llera AS
    Proteomics; 2007 Nov; 7(22):4123-34. PubMed ID: 17994631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
    Basu A; Rodeck U; Prendergast GC; Howe CC
    Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival.
    Capper D; Mittelbronn M; Goeppert B; Meyermann R; Schittenhelm J
    Neuropathol Appl Neurobiol; 2010 Apr; 36(3):183-97. PubMed ID: 20132490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.